Best Chemoembolization of the liver Doctors Worldwide — TOP 41

Chief physician and professor. Grade 1 Expert at the Cancer Center, West China Hospital, Sichuan University (ranked No. 2 in China). Completed a postdoctoral fellowship in interventional radiology at the Chinese PLA General Hospital. Leads multidisciplinary team (MDT) care for complex tumors. Expert in minimally invasive interventional oncology for liver, lung, and pancreatic cancers.

Accreditations: Council Member, WATA. Member of CACA and CMDA committees on intervention, ablation, radioactive seeds, and pain. In 2023, inaugural director member, Palliative Care Committee, Sichuan MDA. Editorial board member of the Chinese Journal of Interventional Imaging and Therapy. Editorial board member of the Chinese Journal of Pain Medicine.

Leads 2 provincial S&T projects and 2 NSFC projects. Has 40+ papers, with 30+ as first or corresponding author. Highest impact factor: 10.73. Hepatocellular carcinoma (HCC) cohort: TACE + lenvatinib vs TACE + sorafenib. OS 18.97 vs 10.77 months. PFS 10.6 vs 5.4 months. ORR 66.8% vs 33.3%.

Dr. Murat Dokdok is a specialized interventional radiologist at Anadolu Medical Center. He completed an interventional neuroradiology fellowship at the University Hospital of Zurich. Dr. Dokdok also held a fellowship at Harvard Medical School. He focuses on neurological therapy and imaging for conditions like cerebral aneurysms and liver cancer. Dr. Dokdok works at Anadolu, a facility affiliated with Johns Hopkins Medicine.

• Holds over 100 national and international scientific publications and presentations.
• Certified by the European Society of Neuroradiology.
• Member of the Cardiovascular and Interventional Radiology Society of Europe.
• Performs radiofrequency ablation and chemoembolization for oncology patients.

Dr. Eda Tanrikulu specializes in medical oncology and chemotherapy at Anadolu Medical Center, with a strong focus on liver cancer treatments.

• Completed medical oncology training at Marmara University
• Ranked 3rd in Turkey's minor specialty exam
• Led medical oncology units at Haydarpaşa Numune Training and Research Hospital
• Participated in international clinical studies

Senior Medical Oncologist Ari Raphael leads groundbreaking clinical trials at Sourasky Medical Center, including innovative studies on T-cell repertoire sequencing.

• Specializes in thoracic malignancies and genomic profiling
• PI for multiple initiator trials in NSCLC treatment
• Moderates the Molecular Tumor Board for lung cancer
• Honored as outstanding teacher at Tel-Aviv University
• Member of ESMO and IASLC professional societies

Dr. Pelles Sharon specializes in advanced liver cancer treatments, including chemoembolization, at Sourasky Medical Center (Ichilov).

• Experienced in diverse cancer treatments with a focus on liver procedures
• Contributed to clinical research on oncologic patients' attitudes
• Skilled in both surgical and non-surgical liver cancer therapies
• Provides personalized treatment plans for each patient

Specializes in chemoembolization of the liver at Sourasky Medical Center – a leading expert in Israel with extensive academic and clinical experience.

• Over 41 years of experience of experience in oncology
• Head of the Unit for Orthopedic Oncology at Sourasky Medical Center
• Member of the European Society of Medical Oncology (ESMO) Sarcoma Faculty
• Associate Professor at Tel-Aviv University & Sackler Faculty of Medicine
• Conducted research on tumor immunology at Felsenstein Medical Research Center

Dr. He Weibing is a pioneer of argon-helium cryoablation in China with more than 20 years of frontline practice. He was a founding member of Fuda Cancer Hospital (Guangzhou). He co-founded its Minimally Invasive Tumor Treatment Center and served as Executive Deputy Director. He also helped found the Ablation Group of the China Anti-Cancer Association. He has been the primary operator in more than 10,000 procedures.

He specializes in tumor cryoablation and is proficient in 125I seed brachytherapy, with a focus on liver and lung cancers. He proposed ten argon-helium techniques. Key co-authored data include: lung cryotherapy n=508; NSCLC n=120 (CR 25.5%, PR 41.8%, 6/12/24-month survival 64%/55%/36%); pancreatic cancer n=38 (median survival 12 months). He served on editorial boards in 2008 and 2010. He has been a national trainer for Varian and Boston Scientific since 2001.

Professor Luo Xiaoping is a nationally recognized interventional radiologist and a leading authority in Western China. He began pioneering vascular interventions in the early 1990s. He helped found the Interventional Group at the Second Affiliated Hospital of Chongqing Medical University.

He has completed over 100,000 interventional procedures, including about 4,000 complex cases. His key skills include TACE for hepatocellular carcinoma, Budd–Chiari interventions, TIPS, and single-stage bilateral stenting for hilar biliary obstruction, with success rates near 100%. He has been a master’s supervisor since 2007. He has trained many physicians, guided complex cases at more than 40 major hospitals across Western China, and helped build interventional programs. He has published 32 papers as first or corresponding author (22 CSCD core, 4 Chinese core, 6 CSCD extended).

Dr. Osama Abdel Mohimen Mohamed leads the Hematology Unit at Shefaa Al Orman Oncology Hospital. He treats complex blood cancers, including leukemia, lymphoma, and myeloma. Dr. Mohamed is a member of the European Society for Medical Oncology. He also holds memberships in the American Society of Hematology and ASBMT.

• Specializes in chemotherapy, immunotherapy, and bone marrow transplantation.
• Manages aggressive acute leukemia and chronic blood disorders.
• Treats complications arising from various solid tumors.
• Works at an ESMO-accredited center that handles 6,000 patients annually.

Professor Xiao Yueyong is Chief Physician in the Department of Radiological Diagnosis at the Chinese PLA General Hospital. He is a leading expert in minimally invasive interventional oncology. He serves as the inaugural President of WATA (2025–). He is President of the International (2020–) and Asian (2012–) Societies of Cryotherapy. He is also Deputy Head of the NHC Expert Group on tumour ablation regulations (2009–).

He has performed over 100,000 CT/MRI‑guided minimally invasive procedures. His work covers chemical ablation, RFA, MWA, cryoablation, and NanoKnife (IRE). He introduced and advanced NanoKnife ablation in China. He led the first national standards for tumour cryoablation and NanoKnife.

Honors include the National Special Contribution Award (Lifetime Honorary). He received First Prize from the Chinese Medicine Education Association (2021). He received two Second Prizes for Military Medical Achievements (2016, 2018) and two Second Prizes from the China Anti‑Cancer Association (2019, 2022). He was named Asian Ablation Master. His research record includes 13 Chinese patents. He is the principal investigator for four NSFC projects and one MOST subject. He has published over 200 papers, with over 110 as first or corresponding author and over 40 in SCI journals. He has led over 10 ablation guidelines or consensus statements.

Dr. Solak specializes in chemoembolization at Hisar Hospital Intercontinental, with training from Hacettepe University Cancer Institute.

• Completed fellowship at Hacettepe University Cancer Institute
• Worked at The University of Texas MD Anderson Cancer Center
• Specializes in gastrointestinal cancers among others
• Board-certified with extensive oncology training

Dr. Yesim Yildirim is a medical oncologist at Anadolu Medical Center. She specializes in immunotherapy and targeted therapy for breast, lung, and gastrointestinal cancers. Dr. Yildirim is ESMO-certified and holds the rank of Professor. She completed training at Mount Vernon in the UK and Rambam Medical Center.

• Authored over 80 scientific publications on tumor biology and precision medicine.
• Treats complex cases including melanoma, sarcomas, and stage 4 lung cancer.
• Member of ASCO and the International Society of Gastrointestinal Oncology.
• Works at Anadolu Medical Center, an affiliate of Johns Hopkins Hospital.

Head of Medical Oncology Division at Sourasky Medical Center – Dr. Wolf brings extensive expertise in oncology and internal medicine.

• Specializes in chemoembolization of the liver
• Degree from Ben Gurion University of the Negev
• Experience in Army Medical Units

Dr. Eda Tanrikulu is a clinical oncologist at Anadolu Medical Center in Istanbul. She ranked 3rd nationally in Turkey's minor specialty medical exam. Dr. Tanrikulu specializes in chemotherapy and individualized cancer treatments. She works at a facility affiliated with the Johns Hopkins Hospital.

• Served as the head of the medical oncology unit at Haydarpaşa Numune Hospital.
• Participated in global training at Oxford University and ESMO in Manchester.
• Treats gastrointestinal, urological, lung, and breast cancers.
• Member of the American and European Societies of Medical Oncology.

Dr. Stepfansky directs oncology hospitalization at Sourasky Medical Center – a leader in liver treatments.

• 26 years of experience in oncology with training at Tel Aviv Medical Center
• Specializes in chemoembolization and other advanced oncology procedures
• Researcher in multiple phases of clinical oncology studies
• Internationally trained professional with Belarus and Israel experience

Over 32 years of experience of surgical expertise – Dr. Ben-haim is among Israel's top specialists for liver and gastrointestinal cancers at Sourasky Medical Center.

• Specializes in complex liver interventions including chemoembolization
• Highly skilled in Whipple procedures for pancreatic tumors
• Senior surgeon at one of Israel's leading cancer centers

Phd Viola Fox leads a certified interdisciplinary cancer center, specializing in advanced liver chemoembolization techniques.

• 14 years of experience in haematology and oncology
• Expert in molecular diagnostics and targeted therapies
• Chief Physician at BKZ Solingen's cancer center
• Member of American Association for Cancer Research
• Active in molecular biology research for cancer treatments

Professor Keil specializes in chemoembolization of the liver, with extensive training under renowned radiologists in Germany.

• Graduated with honors from Julius-Maximilians-Universität Würzburg
• Deepened expertise in interventional radiology at University Hospital of Aachen
• Chief Physician at Academic Hospital Solingen since 2022
• Performs full range of interventional radiology services

Associate Professor specializing in breast, lung, and gastrointestinal cancers – Dr. Ozatli brings targeted expertise to liver chemoembolization cases.

• Internal Medicine Specialist with diverse hospital experience
• Practices at Istinye Liv University Hospital
• Promoted to Associate Professor in 2016
• Studied medicine at Selcuk University

Dr. Ozden completed specialized training in medical oncology at Kocaeli University Faculty of Medicine – a key credential for chemoembolization cases.

• 27 years of experience practicing internal medicine before specializing in oncology
• Trained at Istanbul University's English Medical Program
• Experience across multiple hospital settings